Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Corix Bioscience
AddedFeb 19, 2024
UpdatedJun 18, 2026
Corix Bioscience

Corix Bioscience

Public

Corix Bioscience: An organic biotech firm specializing in cultivating and extracting medicinal CBD oils.

HQ
Irvine, CA, US
Founded
2017
Overview
Compare
Employees

Corix Bioscience is an organic biotechnology company specializing in the cultivation and extraction of cannabidiol (CBD) and tetrahydrocannabivarin (THCV) oils from industrial hemp. The company focuses on providing high-quality CBD products for a variety of medicinal purposes, serving customers across the United States.

Corix Bioscience has made significant strides in the CBD market, leveraging advanced extraction techniques to produce pure and effective oils. Their products are recognized for their medicinal benefits, contributing to the growing acceptance and use of CBD in healthcare.

Corix Bioscience - Quick Facts

When was Corix Bioscience founded?

Corix Bioscience was founded in 2017.

Where is Corix Bioscience's headquarters located?

Corix Bioscience's headquarters is located in Irvine, CA, US.

How many employees does Corix Bioscience have?

Corix Bioscience has 2 employees as of Feb 5, 2024.

Corix Bioscience - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • CBD
  • Oils
NAICS
  • 530000Real Estate and Rental and Leasing
  • 531000Real Estate
  • 531100Lessors of Real Estate
  • 531120Lessors of Nonresidential Buildings (except Miniwarehouses)
SIC
  • 6500Real Estate
  • 6510Real Estate Operators (except Developers) And Lessors
  • 6512Operators of Nonresidential Buildings
ISIC
  • 6810Real estate activities with own or leased property
Show 33 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 459900Other Miscellaneous Retailers
  • 459990All Other Miscellaneous Retailers
  • 459991Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 450000Retail Trade
  • 620000Health Care and Social Assistance
  • 710000Arts, Entertainment, and Recreation
  • 325000Chemical Manufacturing
  • 459000Sporting Goods, Hobby, Musical Instrument, Book, and Miscellaneous Retailers
  • 541000Professional, Scientific, and Technical Services
  • 711000Performing Arts, Spectator Sports, and Related Industries
  • 541700Scientific Research and Development Services
  • 711300Promoters of Performing Arts, Sports, and Similar Events
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 711310Promoters of Performing Arts, Sports, and Similar Events with Facilities
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 7350Miscellaneous Equipment Rental And Leasing
  • 2800Chemicals And Allied Products
  • 5000Wholesale Trade-durable Goods
  • 6000Depository Institutions
  • 7300Business Services
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research